2nd Circ. Wary Of Anti-Competitive Intent In Namenda Plan
The Second Circuit worried Monday that an Actavis PLC unit was trying to thwart generic competition by pulling an older version of Alzheimer's treatment Namenda from the market, but judges grilled...To view the full article, register now.
Already a subscriber? Click here to view full article